Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this is an observational study, obese patients that administed and followed in endocrinology clinic of Marmara University Medical school hospital will follow for clinical and laboratory parameters prospectively for 5 years
Following available clinical and laboratory parameters will be collected for 5 years Treatment modalities ( life stye modification, medication, bariatric surgery) eating habits quality of life body mass index , blood pressure body fat distribution (impedance measurement) laboratory parameters (serum glucose, OGTT, insülin, lipids,creatinin ,ALT AST,CBC, ferritin calcium, phosphate, Parathormone,25 OH vitamin D, vitamin B12 ,uric acid, albumin, FSH LH testosteron, estrogen ) muscle strength (dynomometer measurement) skin glikolization autoflouresent measurement Bone mineral density mesurements (femur, spine ,forarm)
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| life syte modification only | obese patients followed with life style modification |
| |
| medical teatment with antiobesity drugs | patients prescribed antiobesity drugs |
| |
| bariatric surgery | patients undergone bariatric surgery |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| bariatric surgey | Procedure | patients undergone bariatric surgery or prescribed antiobesity drugs |
|
| Measure | Description | Time Frame |
|---|---|---|
| weight loss | %5-10 weight loss | 6 months interval |
| metabolic improvement | blood glucose | 6 months interval |
| metabolic improvement | serum lipid levels | 6 month |
Not provided
Not provided
Inclusion Criteria:
Body mass index over 30 kg/m2 age between 18-65 years
Exclusion Criteria:
active malignancy pregnancy during involvement period chronic inflamatuar diseases
Not provided
Not provided
obese patients refered to our tertiary center for obesity evaluation or treatment
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dilek Gogas Yavuz, MD | Contact | +902166254685 | dilekgogas@marmara.edu.tr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Marmara University Medical School Section of Endocrinology and Metabolism | Recruiting | Istanbul | 34899 | Turkey (Türkiye) |
data will be shared at the second year of recruitment
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| D001836 | Body Weight Changes |
| D000067329 | Obesity, Metabolically Benign |
| D015431 | Weight Loss |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077403 | Orlistat |
| ID | Term |
|---|---|
| D007783 | Lactones |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |